Perspective Therapeutics Inc

NYSE American: CATX    
Share price (4/25/24): $1.60    
Market cap (4/25/24): $939 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.28
from 10-K 13 pages Mayo Foundation for Medical Education and Research Patent License Agreement
12/34/56
EX-10.26
from 10-K 20 pages Registration Rights Agreement
12/34/56
EX-10.6
from 10-K 9 pages Form of Indemnification Agreement
12/34/56
EX-10.3
from 8-K 21 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 16 pages Placement Agency Agreement
12/34/56
EX-10.1
from 8-K 31 pages Investment Agreement
12/34/56
EX-10.3
from 8-K/A 21 pages Option Agreement
12/34/56
EX-10.2
from 8-K/A 38 pages Asset Purchase Agreement by and Between Progenics Pharmaceuticals, Inc., as Seller, Perspective Therapeutics, Inc., as Purchaser, and for Purposes of Section 9.12 Only Lantheus Medical Imaging, Inc. as Guarantor Dated as of January 8, 2024
12/34/56
EX-10.1
from 8-K/A 30 pages Investment Agreement
12/34/56
EX-10.1
from 8-K 19 pages Certain Confidential Information Contained in This Document, Marked by “[**]”, Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential
12/34/56
EX-10.1
from 10-Q 9 pages Confidential Separation Agreement and General Release
12/34/56
EX-10.1
from 8-K 22 pages Perspective Therapeutics, Inc. Second Amended and Restated 2020 Equity Incentive Plan
12/34/56
EX-10.3
from 8-K 17 pages Employment Agreement
12/34/56
EX-10.2
from 8-K 17 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 17 pages Employment Agreement
12/34/56
EX-10.13
from 10-Q 3 pages Promissory Note
12/34/56
EX-10.12
from 10-Q 4 pages Material contract
12/34/56
EX-10.11
from 10-Q 7 pages Lease Document for the University of Iowa Bioventures Centerch 2. Lease Period
12/34/56
EX-10.10
from 10-Q 5 pages 7. Material or Service
12/34/56
EX-10.9
from 10-Q 17 pages Mayo Foundation for Medical Education and Research Know-How License Agreement
12/34/56